pentobarbital will lower the level or impact of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lower the level or impact of alosetron by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Importance Unknown.
Minimal (1)pentobarbital will minimize the level or outcome of paclitaxel protein certain by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
pentobarbital will reduce the level or influence of pioglitazone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
Psychological, tolerance and Actual physical dependence may perhaps occur with continued use; people with psychological dependence on barbiturates may well establish a physical dependence on barbiturates by escalating or decreasing the dosage interval without consulting a physician
Withdrawal signs happen in infants born to mothers who receive barbiturates through the entire last trimester of pregnancy
Contraindicated (1)pentobarbital will reduce the level or outcome of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration. Potent or average CYP3A inducers may decrease cobimetinib systemic exposure by >80% and reduce its efficacy.
pentobarbital will reduce the extent or influence of etonogestrel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will minimize the extent or impact of cilostazol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
fentanyl intranasal and pentobarbital the two boost sedation. Stay away from or Use Alternate Drug. Limit use more info to clients for whom alternative therapy choices are inadequate
pentobarbital will reduce the extent or effect of ibuprofen by impacting hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Unfamiliar.
pentobarbital will lessen the extent or outcome of ramelteon by influencing hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unidentified.
pentobarbital will decrease the extent or influence of nitrendipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.
pentobarbital will lower the level or effect of almotriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.